Remove Clinical Research Remove Drug Trials Remove FDA Approval
article thumbnail

Cardiovascular Clinical Trials with Patient Diversity: Challenges and Considerations

XTalks

This started back in 1993 when the FDA established guidelines to increase diversity by gender and race/ethnicity of participants in clinical trials that were contributing to new drug approvals. Why Should We Care About Diversity and Equity in Clinical Research? In the same webinar, Dr. Hansie M.

article thumbnail

Reimagining Clinical Trials: Why are Virtual Clinical Trials Becoming the New Normal?

Delveinsight

The drug development process is a lengthy and time-intensive process that ends up causing fortunes to industries and organizations sponsoring the process. According to a study by the Tufts Centre for the Study of Drug Development, approximately USD 2.6B Regulatory agencies have always prioritized the well-being of the patients.